NBT Bank N.A. purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 22,752 shares of the financial services provider’s stock, valued at approximately $4,790,000.
Other institutional investors and hedge funds also recently modified their holdings of the company. IFP Advisors Inc raised its holdings in shares of iShares Biotechnology ETF by 39.3% in the second quarter. IFP Advisors Inc now owns 49,988 shares of the financial services provider’s stock worth $9,507,000 after acquiring an additional 14,115 shares during the last quarter. Security National Bank of Sioux City Iowa IA boosted its stake in shares of iShares Biotechnology ETF by 31.8% during the second quarter. Security National Bank of Sioux City Iowa IA now owns 12,187 shares of the financial services provider’s stock valued at $2,318,000 after acquiring an additional 2,939 shares during the last quarter. Kestra Advisory Services LLC boosted its stake in shares of iShares Biotechnology ETF by 12.2% during the first quarter. Kestra Advisory Services LLC now owns 47,461 shares of the financial services provider’s stock valued at $8,014,000 after acquiring an additional 5,155 shares during the last quarter. The Manufacturers Life Insurance Company boosted its stake in shares of iShares Biotechnology ETF by 64.0% during the second quarter. The Manufacturers Life Insurance Company now owns 101,838 shares of the financial services provider’s stock valued at $19,369,000 after acquiring an additional 39,760 shares during the last quarter. Finally, Navellier & Associates Inc. purchased a new stake in iShares Biotechnology ETF during the 2nd quarter worth about $531,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.
iShares Biotechnology ETF Trading Down 1.0%
iShares Biotechnology ETF stock opened at $209.54 on Friday. The stock has a 50-day moving average price of $207.69 and a 200 day moving average price of $189.17. iShares Biotechnology ETF has a 52 week low of $153.50 and a 52 week high of $217.12.
iShares Biotechnology ETF Cuts Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, September 18th. Shareholders of record on Tuesday, September 15th were paid a dividend of $0.0112 per share. The ex-dividend date of this dividend was Tuesday, September 15th. This represents a $0.04 annualized dividend and a dividend yield of 0.0%. This is a decrease from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238.
iShares Biotechnology ETF Company Profile
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
Read More
- Five stocks we like better than iShares Biotechnology ETF
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.
